Compounds > imiquimod

Page last updated: 2024-08-24

imiquimod and Kaposi Disease

imiquimod has been researched along with Kaposi Disease in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (62.50)	29.6817
2010's	2 (25.00)	24.3611
2020's	1 (12.50)	2.80

Authors

Authors	Studies
Avancini, J; Castro, LP; de Oliveira, ZNP; Ferreira, P; Festa Neto, C; Gianotti, MA; Menck, CFM; Pereira, NV; Rivitti, MC; Rocha, LKFL; Samorano, LP	1
Ged, C; Hernández-Martín, A; Knöpfel, N; Latour, I; Taïeb, A; Torrelo, A	1
De Raeve, L; Gutermuth, J; Keymolen, K; Pierret, L; Pintens, S	1
Botella-Estrada, R; Guillen, C; Nagore, E; Requena, C; Sanchez-Pedreño, P; Sanmartin, O; Serra-Guillen, C; Sevila, A	1
Roseeuw, D	1
Difonzo, EM; Giannotti, B; Pimpinelli, N; Vanzi, L	1
Lambert, J; Lapière, K; Nijsten, T	1
Varghese, M; Weisberg, NK	1

Other Studies

8 other study(ies) available for imiquimod and Kaposi Disease

Article	Year
Imiquimod chemoprophylaxis for field cancerization in xeroderma pigmentosum patients-A prospective study. The Australasian journal of dermatology, 2023, Volume: 64, Issue:3 Topics: Chemoprevention; Humans; Imiquimod; Prospective Studies; Skin Neoplasms; Xeroderma Pigmentosum	2023
Reversed actinic damage in two children with xeroderma pigmentosum treated with topical imiquimod. Journal of the European Academy of Dermatology and Venereology : JEADV, 2018, Volume: 32, Issue:7 Topics: Administration, Cutaneous; Antineoplastic Agents; Carcinoma, Basal Cell; Child, Preschool; Eyelid Neoplasms; Humans; Imiquimod; Male; Nose Neoplasms; Skin Neoplasms; Xeroderma Pigmentosum	2018
Xeroderma pigmentosum and leukaemia in two sisters. Journal of the European Academy of Dermatology and Venereology : JEADV, 2016, Volume: 30, Issue:10 Topics: Aminoquinolines; Carcinoma, Basal Cell; Consanguinity; Fatal Outcome; Female; Humans; Imiquimod; Leukemia; Morocco; Siblings; Xeroderma Pigmentosum	2016
Excellent response of basal cell carcinomas and pigmentary changes in xeroderma pigmentosum to imiquimod 5% cream. The British journal of dermatology, 2003, Volume: 149, Issue:4 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Skin Neoplasms; Xeroderma Pigmentosum	2003
The treatment of basal skin carcinomas in two sisters with xeroderma pigmentosum. Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1 Topics: Administration, Topical; Adolescent; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Skin Neoplasms; Treatment Outcome; Xeroderma Pigmentosum	2003
The treatment of basal cell carcinomas in a patient with xeroderma pigmentosum with a combination of imiquimod 5% cream and oral acitretin. Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1 Topics: Acitretin; Administration, Oral; Administration, Topical; Adolescent; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Therapy, Combination; Facial Neoplasms; Humans; Imiquimod; Keratolytic Agents; Male; Treatment Outcome; Xeroderma Pigmentosum	2003
A patient with xeroderma pigmentosum treated with imiquimod 5% cream. Journal of the American Academy of Dermatology, 2005, Volume: 52, Issue:1 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Male; Skin Neoplasms; Xeroderma Pigmentosum	2005
Therapeutic response of a brother and sister with xeroderma pigmentosum to imiquimod 5% cream. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2002, Volume: 28, Issue:6 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Tolerance; Facial Neoplasms; Female; Humans; Imiquimod; Male; Ointments; Skin Neoplasms; Xeroderma Pigmentosum	2002